These codes are not intended to be mandatory, but are to be used as a starting point for the identification of influenza infection in routine Electronic Health Record (EHR). Each study may differ in the sensitivity and specificity of the coding required.
According to the National Health Service (NHS), Influenza is a common infectious viral illness spread by coughs and sneezes. Some of the main symptoms of influenza include: high temperature (fever) of 38C or above, tiredness and weakness, headache, general aches and pains and dry or chesty cough. Cold-like symptoms, such as a blocked or runny nose, sneezing, and a sore throat, can also be caused by influenza, but they tend to be less severe than the other symptoms.
https://www.nhsinform.scot/illnesses-and-conditions/infections-and-poisoning/flu
According to the National Institute for Health and Care Excellence (NICE) guidelines, Influenza is an acute respiratory illness caused by RNA viruses f the family Orthomyxoviridae (influenza viruses). There are three types of influenza virus: Influenza A occurs more frequently and is more virulent. It is responsible for local outbreaks, larger epidemics and pandemics. Influenza B often co-circulates with influenza A during the yearly outbreaks. Generally, influenza B causes less severe clinical illness, although it can still be responsible for outbreaks. Influenza C usually causes a mild or asymptomatic infection similar to the common cold.
Influenza presents with symptoms appearing around 2 days after exposure. Uncomplicated influenza signs and symptoms include: coryza, nasal discharge, cough, fever, gastrointestinal symptoms, headache, malaise, myalgia, arthralgia, ocular symptoms, and sore throat. Complicated influenza is defined by signs and symptoms that: require hospital admission, involve the lower respiratory tract, central nervous system, or cause significant exacerbation of an underlying medical condition.
https://cks.nice.org.uk/topics/influenza-seasonal/
Not found code search
Publications in 2020-2021 identified in PubMed
Moss JWE, Davidson C, Mattock R, Gibbons I, Mealing S, Carroll S. Quantifying the direct secondary health care cost of seasonal influenza in England. BMC Public Health. 2020 Sep 29;20(1):1464. doi: 10.1186/s12889-020-09553-0. PMID: 32993588; PMCID: PMC7526100.
Ramsay J, Minton J, Fischbacher C, Fenton L, Kaye-Bardgett M, Wyper GMA, Richardson E, McCartney G. How have changes in death by cause and age group contributed to the recent stalling of life expectancy gains in Scotland? Comparative decomposition analysis of mortality data, 2000-2002 to 2015-2017. BMJ Open. 2020 Oct 7;10(10):e036529. doi: 10.1136/bmjopen-2019-036529. PMID: 33033012; PMCID: PMC7542937.
Wabe N, Li L, Lindeman R, Post JJ, Dahm MR, Li J, Westbrook JI, Georgiou A. Evaluation of the accuracy of diagnostic coding for influenza compared to laboratory results: the availability of test results before hospital discharge facilitates improved coding accuracy. BMC Med Inform Decis Mak. 2021 May 22;21(1):168. doi: 10.1186/s12911-021-01531-9. PMID: 34022851; PMCID: PMC8141245.
Fitzpatrick T, Malcolm W, McMenamin J, Reynolds A, Guttmann A, Hardelid P. Community-Based Antibiotic Prescribing Attributable to Respiratory Syncytial Virus and Other Common Respiratory Viruses in Young Children: A Population-Based Time-series Study of Scottish Children. Clin Infect Dis. 2021 Jun 15;72(12):2144-2153. doi: 10.1093/cid/ciaa403. PMID: 32270199.
Code repositories
ID- 1 - Repository- Manchester Clinical Codes - Description- Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995-2011: analysis of a large database of primary care consultations - Conditions- URTI - Publication- https://doi.org/10.1093/jac/dku291 - Clinical codes- Read Version 2
ID- 2 - Repository- HDR UK National Phenomics Resource Project - Description- A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service - Conditions- Infections of other or unspecified organs - Publication- https://doi.org/10.1016/S2589-7500(19)30012-3 - Clinical codes- ICD-10
ID- 3 - Repository- HDR UK National Phenomics Resource Project - Description- A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service - Conditions- Lower respiratory tract infections - Publication- https://doi.org/10.1016/S2589-7500(19)30012-3 - Clinical codes- ICD-10
ID- 4 - Repository- HDR UK National Phenomics Resource Project - Description- A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service - Conditions- Viral diseases (excl chronic hepatitis/HIV) - Publication- https://doi.org/10.1016/S2589-7500(19)30012-3 - Clinical codes- ICD-10
ID- 5 - Repository- HDR UK National Phenomics Resource Project - Description- Incidence of Community-Acquired Lower Respiratory Tract Infections and Pneumonia among Older Adults in the United Kingdom: A Population-Based Study - Conditions- Pneumonia - Publication- https://doi.org/10.1371/journal.pone.0075131 - Clinical codes- ICD-10
ID- 6 - Repository- OpenSAFELY - Description- Codes indicating a diagnosis of influenza or influenza-like illness - Conditions- Documented influenza illness - Publication- - Clinical codes- CTV3 (Read V3) with TPP extensions
ID- 7 - Repository- OpenSAFELY - Description- Codes indicating a diagnosis of a lower respiratory tract infection excluding pneumonia - Conditions- Lower respiratory tract infection - Publication- - Clinical codes- CTV3 (Read V3) with TPP extensions
ID- 8 - Repository- OpenSAFELY - Description- Pneumonia ICD-10 codes - Conditions- Pneumonia secondary care - Publication- - Clinical codes- ICD-10
ID- 9 - Repository- LSHTM Data Compass - Description- Code list: ICD-10 codes for pneumonia - Conditions- Pneumonia - Publication- https://doi.org/10.17037/DATA.00000847 - Clinical codes- ICD-10
ID- 10 - Repository- LSHTM Data Compass - Description- Clinical codelist: Read codes and terms used for pneumonia (CPRD) - Conditions- Pneumonia - Publication- https://doi.org/10.17037/DATA.00001654 - Clinical codes- Medcodes
Code | Description | SNOMED CT Concept ID | SNOMED CT Description ID | Read v2 | BREATHE recommended | HDR UK National Phenomics Resource Project 5 |
---|---|---|---|---|---|---|
1010051000006110 | Haemophilus influenzae type B and meningitis C vaccination | 1010051000006106 | 1010051000006110 | N | ||
1024921000006116 | Adverse reaction to *Influenza & Common Cold | 1024921000006100 | 1024921000006116 | N | ||
1048401000006110 | Adverse reaction to Inactivated Influenza (Split Virion) Paediatric | 1048401000006106 | 1048401000006110 | N | ||
1072231000006119 | Adverse reaction to Sanofi Pasteur Inactivated Influenza Split Virion | 1072231000006103 | 1072231000006119 | N | ||
1083051000006115 | Adverse reaction to Inactivated Influenza (Split Virion) | 1083051000006104 | 1083051000006115 | N | ||
1083281000006116 | Adverse reaction to Inactivated Influenza Vaccine, Surface Antigen | 1083281000006100 | 1083281000006116 | N | ||
1113881000006112 | Adverse reaction to Uniflu Plus Gregovite C | 1113881000006108 | 1113881000006112 | N | ||
1116591000006118 | Adverse reaction to Haemophilus Influenzae Type B Polysaccharide | 1116591000006102 | 1116591000006118 | N | ||
1118771000006112 | Adverse reaction to *Influenza & Common Cold | 1118771000006108 | 1118771000006112 | N | ||
1119661000006117 | Adverse reaction to Haemophilus influenzae type b polysaccharide, conjugated | 1119661000006101 | 1119661000006117 | N | ||
1120351000000115 | Influenza A virus H1N1 subtype contact | 444426005 | 1179031000000118 | 65PT.00 | N | |
1122041000000117 | Swine influenza contact | 444426005 | 1651131000000116 | 65PT.11 | N | |
1122831000000118 | Suspected Influenza A virus subtype H1N1 infection | 505251000000100 | 1122831000000118 | 1J72.00 | Y | |
1125021000006114 | Adverse reaction to Haemophilus Influenzae B Polysaccaride Conjugated To Tetanus Protein | 1125021000006105 | 1125021000006114 | N | ||
1125031000006112 | Adverse reaction to Haemophilus Influenzae B Polysaccaride Conjugated To Diphtheria Protein | 1125031000006108 | 1125031000006112 | N | ||
1126371000000114 | Influenza A virus H1N1 subtype detected | 711330007 | 3078435012 | 4J3L.00 | Y | |
1126431000000117 | Influenza A virus H1N1 subtype not detected | 711334003 | 3078060015 | 4J3M.00 | N | |
1126551000000111 | Local flu response centre notified | 506871000000103 | 1126551000000111 | 9G5..00 | N | |
1126621000000117 | Influenza A virus H1N1 subtype close contact | 506901000000103 | 1126621000000117 | 65PV.00 | N | |
1128141000000118 | Influenza A (H1N1) swine flu | 442696006 | 1128141000000118 | H2A..11 | Y | |
1131081000006113 | Adverse reaction to Inactivated Influenza Vaccine | 1131081000006109 | 1131081000006113 | N | ||
1135701000000110 | Possible influenza A virus H1N1 subtype | 506751000000104 | 1135701000000110 | 1W0..00 | Y | |
1136091000000113 | History of influenza vaccination | 473169009 | 2955980010 | 14b3.00 | N | |
1138151000000117 | Advice given about Influenza A virus subtype H1N1 infection | 511781000000101 | 1138151000000117 | 8CAR.00 | N | |
1143141000000112 | Influenza A virus subtype H1N1 serology | 1002251000000108 | 2584601000000116 | 4JDe.00 | N | |
1143761000006119 | Adverse reaction to Haemophilus Influenzae (Lyophilized Bacterial Lysates) | 1143761000006103 | 1143761000006119 | N | ||
1149291000000110 | No response to influenza vaccination invitation | 516101000000103 | 1149291000000110 | 68Nu.00 | N | |
1158771000000112 | Consent given for influenza A subtype H1N1 vaccination | 518961000000102 | 1158771000000112 | 68Nt.00 | N | |
1161531000000115 | Advice given about swine flu by telephone | 520171000000102 | 1161531000000115 | 8CAR011 | N | |
11931191000006114 | Influenza vaccination requested | 785541000000100 | 1756791000000118 | N | ||
11934921000006113 | Administration of first quadrivalent (QIV) inactivated seasonal influenza vaccination | 11934921000006109 | 11934921000006113 | N | ||
11934931000006111 | Administration of first non adjuvanted trivalent (TIV) inactivated seasonal influenza vaccination | 11934931000006107 | 11934931000006111 | N | ||
11934951000006116 | Administration of second non adjuvanted trivalent (TIV) inactivated seasonal influenza vaccination | 1.19349510000061e+16 | 11934951000006116 | N | ||
11934961000006119 | Administration of adjuvanted trivalent (aTIV) inactivated seasonal influenza vaccination | 11934961000006103 | 11934961000006119 | N | ||
11934971000006114 | First quadrivalent (QIV) inactivated seasonal influenza vaccination given by pharmacist | 11934971000006105 | 11934971000006114 | N | ||
11934981000006112 | First non adjuvanted trivalent (TIV) inactivated seasonal influenza vaccination given by pharmacist | 11934981000006108 | 11934981000006112 | N | ||
11935001000006115 | Second non adjuvanted trivalent (TIV) inactivated seasonal influenza vaccination given by pharmacist | 11935001000006104 | 11935001000006115 | N | ||
11935021000006113 | Administration of first quadrivalent (QIV) inactivated seasonal influenza vaccination given by other healthcare provider | 11935021000006109 | 11935021000006113 | N | ||
11935031000006111 | Administration of first non adjuvanted trivalent (TIV) inactivated seasonal influenza vaccination given by other healthcare provider | 11935031000006107 | 11935031000006111 | N | ||
11935061000006119 | Administration of adjuvanted trivalent (aTIV) inactivated seasonal influenza vaccination given by other healthcare provider | 11935061000006103 | 11935061000006119 | N | ||
11935071000006114 | Administration of second quadrivalent (QIV) inactivated seasonal influenza vaccination given by other healthcare provider | 11935071000006105 | 11935071000006114 | N | ||
11935081000006112 | Adjuvanted trivalent (aTIV) inactivated seasonal influenza vaccination given by pharmacist | 11935081000006108 | 11935081000006112 | N | ||
11935091000006110 | Administration of second non adjuvanted trivalent (TIV) inactivated seasonal influenza vaccination given by other healthcare provider | 11935091000006106 | 11935091000006110 | N | ||
11935101000006116 | Second quadrivalent (QIV) inactivated seasonal influenza vaccination given by pharmacist | 1.19351010000061e+16 | 11935101000006116 | N | ||
11935111000006118 | Administration of second quadrivalent (QIV) inactivated seasonal influenza vaccination | 11935111000006102 | 11935111000006118 | N | ||
11966421000006117 | Adverse reaction to Influenza Vaccine Tetra Myl | 11966421000006101 | 11966421000006117 | N | ||
11989891000006112 | Adverse reaction to Influenza Myl | 11989891000006108 | 11989891000006112 | N | ||
1206286018 | Haemophilus influenzae septicaemia | 447685007 | 2898280014 | A384100 | Y | |
1227545013 | [V]Flu - influenza vaccination | 1411000119106 | 2916683016 | ZV04811 | N | |
1229740013 | Influenza with bronchopneumonia | 41269000 | 1229740013 | H270000 | Y | |
1232627018 | Pneumonia due to parainfluenza virus | 64917006 | 499984015 | H202.00 | Y | |
123962018 | Influenza with encephalopathy | 74644004 | 123962018 | H27y000 | Y | |
1256621000033114 | Influenza virus inactivated split (H1N1, H3N2-like, B/Brisbane/60/2008-like, strains) | 1256621000033105 | 1256621000033114 | N | ||
12589011000006116 | Adverse reaction to Influenza virus inactivated split (H1N1, H3N2-like, B/Brisbane/60/2008-like, strains) | 1.25890110000061e+16 | 12589011000006116 | N | ||
12680721000006111 | Hib (Haemophilus influenzae type b) and meningococcal group C vaccination | 428975001 | 2772561000000117 | N | ||
12681331000006117 | First diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination | 1082441000000108 | 2772741000000110 | N | ||
12681341000006110 | Second diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination | 1082451000000106 | 2772751000000113 | N | ||
12681351000006112 | Third diphtheria, tetanus, whooping cough, Hib (Haemophilus influenzae type b), polio and hepatitis B vaccination | 1082461000000109 | 2772761000000111 | N | ||
12715991000006110 | [X]Influenza vaccine causing adverse effects in therapeutic use | 104371000000107 | 160081000000117 | N | ||
12721231000006111 | Pneumonia or influenza NOS | 540151000000108 | 1204911000000119 | Y | ||
13002211000006112 | Seasonal influenza vaccination given in school | 1239861000000100 | 2801761000000112 | N | ||
142934010 | Influenza vaccination | 86198006 | 142934010 | 65E..00 | N | |
1484830012 | Influenza vaccination contraindicated | 390796006 | 1484830012 | 8I2F.00 | N | |
1485436015 | Parainfluenza virus antibody level | 1005101000000108 | 2561381000000118 | 43dg.00 | N | |
1485437012 | Parainfluenza type 2 antibody level | 1005091000000100 | 2560781000000114 | 43df.00 | N | |
1485540014 | Parainfluenza type 3 antibody level | 1005111000000105 | 2556351000000110 | 43dh.00 | N | |
151462017 | Haemophilus influenzae infection | 91428005 | 151462017 | A3B5.00 | Y | |
1783752014 | Haemophilus influenzae B IgG level | 996761000000106 | 2572551000000119 | 43WV.00 | N | |
1784697017 | Influenza A antigen level | 1001341000000106 | 2573071000000110 | 43k2.00 | N | |
1784698010 | Influenza B antigen level | 1001351000000109 | 2563871000000113 | 43k3.00 | N | |
1792361000000119 | Influenza A nucleic acid detection | 1029881000000100 | 2595551000000117 | 43w6.00 | N | |
1803861000006110 | Adverse reaction to Influenza Virus Live Attenuated | 1803861000006106 | 1803861000006110 | N | ||
1804181000006111 | Adverse reaction to Influenza Vaccine (Live Attenuated) | 1804181000006107 | 1804181000006111 | N | ||
2395701000000111 | Long term indication for seasonal influenza vaccination | 935351000000106 | 2395701000000111 | 8BQ1.00 | N | |
2397631000033114 | Influenza Myl | 2397631000033105 | 2397631000033114 | N | ||
2608911000000114 | Influenza due to zoonotic influenza virus | 1033051000000101 | 2608911000000114 | Y | ||
2608951000000113 | Influenza due to pandemic influenza virus | 1033071000000105 | 2608951000000113 | Y | ||
2608991000000117 | Influenza due to seasonal influenza virus | 1033091000000109 | 2608991000000117 | Y | ||
2609031000000111 | Influenza with pneumonia due to seasonal influenza virus | 1033111000000104 | 2609031000000111 | Y | ||
2636251000000110 | Parainfluenza group RNA (ribonucleic acid) detection assay | 1046151000000109 | 2636251000000110 | N | ||
265445015 | Influenza vacc consent given | 171290003 | 2837355012 | 68NV.00 | N | |
2820795016 | Influenza due to Influenza A virus subtype H1N1 | 442696006 | 2820795016 | H2A..00 | Y | |
285858017 | Has 'flu vaccination at home | 185900003 | 285858017 | 9OX1.00 | N | |
285859013 | Has'flu vaccination at surgery | 185901004 | 285859013 | 9OX2.00 | N | |
288067017 | [X]Haemophilus influenzae infection, unspecified | 91428005 | 151462017 | Ayu3U00 | Y | |
296887012 | Post influenza vaccination encephalitis | 192721000 | 296887012 | F034G00 | Y | |
301057016 | Acute haemophilus influenzae laryngitis | 195684009 | 301057016 | H040400 | Y | |
301108016 | Acute haemophilus influenzae bronchitis | 195721005 | 301108016 | H060800 | Y | |
301413010 | Influenza with pneumonia, influenza virus identified | 195878008 | 301357010 | H270100 | Y | |
301414016 | Influenza with pneumonia NOS | 195878008 | 301357010 | H270z00 | Y | |
301415015 | Influenza with other respiratory manifestation | 6142004 | 11203012 | H271.00 | Y | |
301416019 | Influenza with laryngitis | 195923003 | 301416019 | H271000 | Y | |
301417011 | Influenza with pharyngitis | 195924009 | 301417011 | H271100 | Y | |
301418018 | Influenza with respiratory manifestations NOS | 6142004 | 11203012 | H271z00 | Y | |
301421016 | Influenza with other manifestations | 6142004 | 11203012 | H27y.00 | Y | |
301424012 | Influenza with other manifestations NOS | 6142004 | 11203012 | H27yz00 | Y | |
301431011 | Pneumonia or influenza NOS | 195878008 | 301357010 | H2z..00 | Y | |
3555871000006115 | Parainfluenza virus pneumonia | 64917006 | 107903018 | Y | ||
3555891000006119 | Pneumonia due to parainfluenza virus | 64917006 | 1232627018 | Y | ||
3555901000006115 | Parainfluenza pneumonia | 64917006 | 3035270018 | Y | ||
387051000006110 | [X]Flu+oth respiratory manifestations,'flu virus identified | 6142004 | 11203012 | Hyu0400 | Y | |
388291000006111 | [X]H influenzae as cause/diseases classified/other chapters | 91428005 | 151462017 | AyuKC00 | Y | |
389901000006115 | [X]Influenza+other manifestations,influenza virus identified | 6142004 | 11203012 | Hyu0500 | Y | |
396106019 | Influenza NOS | 6142004 | 11203012 | H27z.00 | Y | |
4063911000006112 | Influenza like illness | 95891005 | 2920741013 | Y | ||
407721000000118 | Haemophilus influenzae type B and meningitis C vaccination | 428975001 | 1664081000000114 | 65b..00 | Y | |
456021000006115 | Acute bronchitis due to parainfluenza virus | 195726000 | 301114011 | H060C00 | Y | |
459620016 | Influenza A antibody level | 1014261000000103 | 2582871000000118 | 43dF.00 | N | |
459621017 | Influenza B antibody level | 1014271000000105 | 2552471000000113 | 43dG.00 | N | |
460150015 | H/O: influenza vaccine allergy | 294647003 | 434938013 | 14LJ.00 | N | |
460160012 | Influenza vaccination invitation letter sent | 315641001 | 460160012 | 9OX6.00 | N | |
4780481000006116 | Acute parainfluenza virus bronchitis | 195726000 | 301114011 | Y | ||
498121000033114 | Haemophilus Influenzae B Polysaccaride Conjugated To Tetanus Protein | 498121000033105 | 498121000033114 | N | ||
498321000033111 | Haemophilus Influenzae B Polysaccaride Conjugated To Diphtheria Protein | 498321000033107 | 498321000033111 | N | ||
546421000006115 | Chest infection - influenza with pneumonia | 195878008 | 301357010 | H270.11 | Y | |
5791421000006116 | Influenza split virion vaccine adverse reaction | 293112000 | 433297017 | N | ||
5791431000006118 | Influenza surface antigen vaccine adverse reaction | 293113005 | 433298010 | N | ||
642021000033115 | Inactivated Influenza (Split Virion) | 642021000033104 | 642021000033115 | N | ||
676781000000110 | Influenza H1 virus detected | 441043003 | 2882417014 | 4JU0.00 | Y | |
676841000000114 | Influenza H2 virus detected | 440927002 | 3034688012 | 4JU1.00 | Y | |
676901000000115 | Influenza H3 virus detected | 441049004 | 2882421019 | 4JU2.00 | Y | |
676961000000116 | Influenza H5 virus detected | 441343005 | 2882423016 | 4JU3.00 | Y | |
677021000000113 | Influenza A virus, other or untyped strain detected | 359351000000100 | 676741000000119 | 4JU4.00 | Y | |
677081000000114 | Influenza B virus detected | 441345003 | 2794563017 | 4JU5.00 | Y | |
689941000000115 | Human parainfluenza virus detected | 441344004 | 2790535011 | 4JUF.00 | Y | |
712231000033111 | Sanofi Pasteur Inactivated Influenza Split Virion | 712231000033107 | 712231000033111 | N | ||
7267051000006117 | Influenza A (H1N1) | 442696006 | 2820794017 | Y | ||
7267061000006115 | Influenza caused by Influenza A virus subtype H1N1 | 442696006 | 3291265019 | Y | ||
7293041000006114 | Exposure to Influenza A virus subtype H1N1 | 444426005 | 2840615016 | N | ||
7293051000006111 | Exposure to swine influenza virus | 444426005 | 2840616015 | N | ||
762181000006116 | Flu like illness | 95891005 | 1235951017 | H27z.11 | Y | |
7649691000006115 | Haemophilus influenzae type b infection | 709410003 | 3039757019 | Y | ||
7649701000006115 | Hib (Haemophilus influenzae type b) infection | 709410003 | 2496051000000114 | Y | ||
7696051000006119 | First vaccination with Haemophilus influenzae type B and Neisseria meningitidis serotype C combination vaccine | 712834006 | 3285842011 | N | ||
778711000006116 | Influenza like illness | 95891005 | 158839016 | H27z.12 | Y | |
778871000006116 | Influenza with pneumonia | 195878008 | 301357010 | H270.00 | Y | |
808051000006112 | H influenzae as cause/diseases classified/other chapters | 91428005 | 151462017 | A3BXD00 | Y | |
8190511000006118 | Suspected influenza A virus subtype H1N1 infection | 505251000000100 | 1135801000000116 | Y | ||
843921000033117 | *Influenza & Common Cold | 843921000033101 | 843921000033117 | Y | ||
851321000033116 | Haemophilus influenzae type b polysaccharide, conjugated | 851321000033100 | 851321000033116 | N | ||
880121000033116 | Haemophilus Influenzae Type B Polysaccharide | 880121000033100 | 880121000033116 | N | ||
885251000006114 | Influenza + pneumonia | 195878008 | 885251000006114 | H270.99 | Y | |
885261000006111 | Influenza + encephalopathy | 74644004 | 885261000006111 | H27y099 | Y | |
885271000006116 | Pneumonia/influenza NOS | 540151000000108 | 885271000006116 | H2z..99 | Y | |
906821000033118 | Haemophilus Influenzae (Lyophilized Bacterial Lysates) | 906821000033102 | 906821000033118 | N | ||
924501000006111 | Influenza vaccination | 924501000006107 | 924501000006111 | N | ||
931801000006112 | [X]Influenza vaccine causing adverse effects therapeutic use | 420113004 | 2578720016 | U60K400 | N | |
932221000006114 | Adv react: influenza vaccine | 104371000000107 | 932221000006114 | U60K499 | N | |
955561000006112 | Adverse reaction to influenza vaccine | 955561000006108 | 955561000006112 | N | ||
966421000033119 | Inactivated Influenza Virus Whole Virion Vero Cell Derived | 966421000033103 | 966421000033119 | N | ||
966521000033115 | Inactivated Influenza Virus Split Virion Adjuvanted | 966521000033104 | 966521000033115 | N | ||
No found code | Chest infection- influenza with pneumonia | 195878008 | 301357010 | H270.11 | Y | Y |
Code | Description | BREATHE recommended | Open Safely 5 | Open Safely 6 |
---|---|---|---|---|
G5203 | Acute myocarditis - influenza | Y | Y | |
H2... | Pneumonia and influenza | Y | Y | Y |
H27.. | Influenza | Y | Y | Y |
H270. | Influenzal pneumonia | Y | Y | Y |
H2700 | Influenza with bronchopneumonia | Y | Y | Y |
H2701 | Influenza with pneumonia, influenza virus identified | Y | Y | Y |
H270z | Influenza with pneumonia NOS | Y | Y | Y |
H271. | Influenza with other respiratory manifestation | Y | Y | Y |
H2710 | Influenza with laryngitis | Y | Y | Y |
H2711 | Influenza with pharyngitis | Y | Y | Y |
H271z | Influenza with respiratory manifestations NOS | Y | Y | Y |
H27y. | Influenza with other manifestations | Y | Y | Y |
H27y0 | Influenza with encephalopathy | Y | Y | Y |
H27y1 | Influenza with gastrointestinal tract involvement | Y | Y | Y |